Partnerships, Pilots and Mergers 2.0: What Should We Expect?

After a tumultuous 2023 for digital health, marked by consolidation, declining funding, and a notable shift in investment dynamics, is the tide set to turn in 2024? Indicators from Q1 would suggest so, with $5.1 billion recorded across 347 deals in the space, with US deals matching the same period in 2023 and European deals surpassing it by 22%, setting a cautiously positive stage for the remainder of the year.

It appears in the face of ongoing disruptions, the pharmaceutical industry persists in leveraging digital technology to enhance patient care and drug safety. However, careful selection of partners and strategic planning are imperative for long-term success amidst industry uncertainties.

Join industry leaders in an engaging virtual roundtable as we delve into the future of the digital health landscape. From pharma giants to the agile startups reshaping the industry, we explore the intricate dance of partnerships, pilots, and mergers 2.0. 

• What groundbreaking collaborations will define the next era of healthcare? 

• What challenges and opportunities lie ahead for payers, providers, and innovators alike? 

Don't miss this insightful discussion on navigating the evolving terrain of digital health.